In the News
High-sensitivity C-reactive protein level predicted mortality risk in recent-onset type 2 diabetes
While high-sensitivity C-reactive protein was a good predictor of mortality, C-peptide levels were more closely associated with cardiovascular events, and having high levels of both was associated with increased risk of either outcome, a prospective study in Denmark found.
NSAID use linked to risk of heart failure hospitalization in type 2 diabetes
Danish patients with type 2 diabetes who took prescription NSAIDs had increased risk of first-time heart failure hospitalization, particularly if they were new users of the drugs or age 65 years or older, a recent study found.
Younger patients often ration insulin due to cost, study finds
Data from the 2021 National Health Interview Survey indicate that one in five patients younger than age 65 years, who would not be eligible for the $35 monthly Medicare price cap, have skipped or reduced insulin doses or put off buying the drug to save money.
MKSAP quiz: New unsteadiness while walking in type 2 diabetes
This month's quiz asks readers to evaluate a 66-year-old man with type 2 diabetes, diagnosed 6 years ago, who has had fatigue and unsteadiness while walking for the past 4 months.
Spotlight on statins in diabetes
Recent studies looked at how statins negatively affect glycemic control but improve cardiovascular mortality, as well as the reasons patients with diabetes don't receive prescriptions for statins despite recommendations.
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients age 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
New safety alert for certain continuous glucose monitoring systems
Glucose readers in the FreeStyle Libre product family have the potential for battery swelling and overheating if not properly stored, charged, or used.